UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED CONDENSED STATEMENT OF CASH FLOW - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 3,217	$ 2,667
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	149	149
Amortization	592	626
Provision for (recovery of) losses on accounts receivable	(13)	1
Deferred income taxes	(117)	(131)
Stock-based compensation expense	21	22
Changes in operating assets and liabilities:
Accounts receivable	(782)	(432)
Accrued interest and other receivables	(16)	10
Inventories	(133)	(117)
Prepaid expenses and other current assets	(45)	(20)
Accounts payable	337	(106)
Accrued expenses	923	(426)
Total adjustments	916	(424)
Net cash provided by operating activities	4,133	2,243
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures for property and equipment	(48)	(68)
Capital expenditures for intangible assets	(4)	(2)
Net cash provided by (used in) investing activities	(52)	(70)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock - options	148	72
Common stock purchased and retired	0	0
Tax benefit attributable to exercise of stock options	19	17
Repayment of notes payable	0	(4,778)
Payment of dividends	0	0
Net cash provided by (used in) financing activities	167	(4,689)
Effect of exchange rate changes on cash	(10)	(656)
Net increase (decrease) in cash and cash equivalents	4,238	(3,172)
Cash at beginning of period	23,278	19,274
Cash at end of period	27,516	16,102
Cash paid during the period for income taxes	345	1,138
Cash paid during the period for interest	$ 0	$ 65